For the Inventor, By the Inventor

Enter assignee name

Worcester, MA, United States of America

Athena Diagnostics, Inc.

USPTO Granted Patents = 23

% Expired Patents = 17.4

CIPO Patents = 8

EPO Patents = 1

Trademarks = 9

Forward Citations = 31

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Corey D Braastad (9 out of 10 patents)

Jeffrey George Jones (9 out of 10 patents)

William K Seltzer (8 out of 8 patents)

4. Susan Kimberly Allen (8 out of 8 patents)

5. Sat Dev Batish (6 out of 6 patents)

6. Normand J Robichaud (6 out of 6 patents)

7. Narasimhan Nagan (5 out of 11 patents)

8. Hui Zhu (5 out of 6 patents)

9. Terry J Watnick (3 out of 6 patents)

10. Jeffery G Jones (3 out of 3 patents)

11. Gregory G Germino (3 out of 9 patents)

12. David A Hill (3 out of 3 patents)

13. Matthew Evans (3 out of 6 patents)

14. John A Curran (3 out of 3 patents)

15. Jing Wang (3 out of 3 patents)

23 patents: Sort by Forward Citations

1. 12497658 - METHODS TO DETECT A SILENT CARRIER GENOTYPE (2025-12-16),

2. 11655508 - PKD mutations and evaluation of same (2023-05-23),

3. 11512352 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2022-11-29),

4. 10762981 - Pathogenicity scoring system for human clinical genetics (2020-09-01),

5. 10760128 - PKD mutations and evaluation of same (2020-09-01),

6. 10697016 - Methods to detect a silent carrier genotype (2020-06-30),

7. 10227650 - Methods to detect a silent carrier of a null allele genotype (2019-03-12),

8. 9611512 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2017-04-04),

9. 8785122 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2014-07-22),

10. 8771946 - PKD mutations and evaluation of same (2014-07-08),

11. 8192933 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2012-06-05),

12. 7824860 - Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH) (2010-11-02),

13. 7799529 - Nephrin gene and protein (2010-09-21),

14. 7704691 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2010-04-27),

15. 7521190 - Compositions and methods for genetic analysis of polycystic kidney disease (2009-04-21),

Athena Diagnostics, Inc. is a leader in the field of genetic testing, specializing in the development of diagnostic solutions for neurological disorders. The company focuses on providing comprehensive testing services that aid in the diagnosis of conditions such as epilepsy, neuromuscular diseases, and other genetic disorders. Based in Worcester, MA, Athena Diagnostics leverages advanced molecular technologies to enhance patient care and support healthcare professionals in making informed decisions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Athena Diagnostics, Inc.

23 Patents

#15 in Worcester, MA

#866 in Massachusetts

#14,415 in US

#27,649 in the World

Worcester, MA, United States of America

Athena Diagnostics, Inc.

Forward Citations = 31

40 inventors:

Corey D Braastad (9 out of 10 patents)

Jeffrey George Jones (9 out of 10 patents)

William K Seltzer (8 out of 8 patents)

4. Susan Kimberly Allen (8 out of 8 patents)

5. Sat Dev Batish (6 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…